Arsenal Capital Partners Acquires BresMed Health Solutions
February 26, 2020
Arsenal Capital Partners acquired BresMed Health Solutions as the first investment to form a new value demonstration platform focused on market access, health economics, outcomes research, patient preference and real-world evidence. BresMed — a global health economics and outcomes research consultancy with more than 150 staff across the U.K., Ireland, the Netherlands, the U.S. and India — will continue to be led by founder Nic Brereton and will join Arsenal’s new platform led operationally by Jon Williams.
- Buyers
- Arsenal Capital Partners
- Targets
- BresMed Health Solutions
- Industry
- Healthcare Services
- Location
- United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Arsenal Capital Partners Acquires Endpoint Clinical and Fortrea Patient Access from Fortrea
March 11, 2024
Healthcare Services
Arsenal Capital Partners has acquired Fortrea's Endpoint Clinical and Fortrea Patient Access businesses in a divestiture completed June 4, 2024. The sale allows Fortrea to sharpen its focus as a pure‑play CRO while Arsenal will position Endpoint and the Patient Access business for accelerated investment and growth under management led by Sam Osman.
-
Arsenal Capital Partners Acquires Majority Stake in OncoHealth; McKesson Makes Strategic Investment
May 9, 2022
Healthcare Services
Arsenal Capital Partners has acquired a majority ownership stake in OncoHealth, a digital health company focused on oncology, with McKesson Corporation making a strategic minority investment. Baird Capital, the prior investor, will retain a minority equity stake; financial terms were not disclosed. The investments are intended to accelerate OncoHealth’s product innovation, expansion of oncology digital solutions, and market growth.
-
Arsenal's Value Demonstration Business Acquires Cyan Health
December 8, 2021
Healthcare Services
Arsenal Capital Partners' Value Demonstration business has acquired Cyan Health, a Montclair, New Jersey–based payer marketing and market-access agency. The add-on strengthens Arsenal's Value Demonstration platform capabilities in market access, payer communications, and value demonstration to support life sciences clients and accelerate patient access to new therapies.
-
Value Demonstration (Arsenal) Acquires Guidemark Health
November 2, 2021
Healthcare Services
Arsenal Capital Partners, through its Value Demonstration healthcare platform, has acquired Guidemark Health, a U.S.-based healthcare marketing communications, training, and medical education agency. The acquisition is the third add-on to Arsenal’s Value Demonstration organization and is intended to deepen the platform’s customer engagement, medical communications, and oncology/rare disease capabilities.
-
Arsenal Capital Partners Acquires Hopebridge; Baird Capital Retains Minority Stake
May 6, 2019
Healthcare Services
Arsenal Capital Partners has acquired Hopebridge, a center-based provider of behavioral health and autism therapy services headquartered in Indianapolis. Baird Capital sold its stake but will retain a minority investment; financial terms were not disclosed and Arsenal said it will support platform investments to expand Hopebridge's services and footprint.
-
Arsenal Capital Partners Acquires Accumen
January 17, 2019
Healthcare Services
Arsenal Capital Partners, a New York-based private equity firm, has acquired Accumen Inc., a technology-enabled provider of health system performance optimization solutions, from Accretive, LLC. Terms were not disclosed; Arsenal said it will support Accumen's growth and expand its technology-enabled services for clinical laboratories, outreach services, patient blood management, and imaging services.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.